Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 09-2003 | 06-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,693 | 8,157 | N/A | N/A | N/A |
| Marketable Securities | 37,465 | 40,636 | N/A | N/A | N/A |
| TOTAL | $44,905 | $50,258 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 2,549 | 2,761 | N/A | N/A | N/A |
| Other Non-Current Assets | 295 | 285 | 0 | 0 | 0 |
| TOTAL | $2,844 | $3,045 | $N/A | $N/A | $N/A |
| Total Assets | $47,750 | $53,304 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,059 | 2,604 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,450 | 1,985 | 0 | 0 | 0 |
| Accrued Expenses | 3,201 | 2,990 | N/A | N/A | N/A |
| TOTAL | $9,364 | $9,565 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,026 | 946 | N/A | N/A | N/A |
| Deferred Revenues | 1,654 | 1,987 | N/A | N/A | N/A |
| TOTAL | $1,026 | $946 | $N/A | $N/A | $N/A |
| Total Liabilities | $10,390 | $10,512 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 16,867 | 16,866 | N/A | N/A | N/A |
| Common Shares | 2 | 2 | N/A | N/A | N/A |
| Retained earnings | -86,948 | -80,734 | N/A | N/A | N/A |
| Other shareholders' equity | -2,467 | -3,102 | 0 | 0 | 0 |
| TOTAL | $37,359 | $42,792 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $47,750 | $53,304 | $0 | $0 | $0 |